Keyphrases
Parkinson's Disease
100%
Nigrostriatal System
100%
Dopaminergic Neurons
100%
Dopamine Oxidation
100%
Neuromelanin
66%
Aminochrome
50%
New Drugs
33%
Neurodegeneration
33%
Pathophysiology
16%
Healthy Individuals
16%
Normal Brain
16%
Mitochondria
16%
Pharmacological Therapy
16%
Alpha-synuclein (α-syn)
16%
Neuroinflammation
16%
Neurotoxicity
16%
Effective Compounds
16%
L-DOPA
16%
Melanin
16%
Endoplasmic Reticulum Stress (ER stress)
16%
Protein Degradation
16%
Substantia Nigra Pars Compacta
16%
Degradation System
16%
DT-diaphorase
16%
Neurotoxic Oligomers
16%
Glutathione Transferase M2-2
16%
INIS
dopamine
100%
losses
100%
metabolites
100%
nervous system diseases
100%
neurons
100%
oxidation
100%
drugs
50%
therapy
16%
humans
16%
information
16%
brain
16%
mitochondria
16%
proteins
16%
enzymes
16%
glutathione
16%
cytoplasm
16%
transferases
16%
dopa
16%
melanin
16%
endoplasmic reticulum
16%
diaphorase
16%
Neuroscience
Parkinson's Disease
100%
Dopaminergic Neuron
100%
Neuromelanin
66%
Neurodegeneration
33%
Mitochondrion
16%
Substantia Nigra Pars Compacta
16%
Endoplasmic Reticulum Stress
16%
Oligomer
16%
Melanin
16%
Neurotoxicity
16%
Reduced Nicotinamide Adenine Dinucleotide (Phosphate) Dehydrogenase (Quinone)
16%
Glutathione Transferase M2
16%
Drug Therapy
16%
Biochemistry, Genetics and Molecular Biology
Metabolite
100%
Dopaminergic
100%
Neuromelanin
66%
Protein Catabolism
16%
Glutathione S-Transferase
16%
Normal Human
16%
Mitochondrion
16%
Enzyme
16%
Endoplasmic Reticulum Stress
16%
Dihydrolipoamide Dehydrogenase
16%
Drug Therapy
16%